Baicheng Medical Technology

Hangzhou Baicheng Medical Technology is a leading Chinese Contract Research Organization (CRO) that provides comprehensive pharmaceutical R&D services. The company specializes in pharmaceutical research, clinical trial management, and bioequivalence (BE) studies, with a particular strength in generic drug development and consistency evaluation. Baicheng Medical operates an integrated platform that covers the entire drug development lifecycle, from pharmacy research to regulatory submission and clinical execution. In addition to its service-based model, the company engages in the self-development of drug technologies for subsequent transfer or licensing to pharmaceutical manufacturers. Listed on the Shenzhen Stock Exchange, Baicheng Medical is a key player in accelerating drug market entry within the Chinese healthcare ecosystem.